Metagenomics is a sequencing-based analytical method used to profile gut microbiota at high resolution and to discover biomarkers from complex microbial communities. It is especially useful in integrated multi-omics studies, where metagenomic data can be combined with other layers to explain functional outputs such as antioxidant biomarker formation during fermentation. In diagnostics, it supports microbiome-based disease stratification, including inflammatory bowel disease, and in oncology it has been used to build predictive models from multiple immune checkpoint inhibitor-treated cohorts. A key recent advance is the use of gene-level gut microbiome signatures across multiple cancer types to predict response to immune checkpoint inhibitors, highlighting its role in precision medicine. Another study showed that integrated metagenomic data were used to build BioP-VAE, underscoring its value as a foundational data type for machine-learning models.
Microbiome profiling and diagnostics
- Sequencing-based metagenomics enabled high-resolution profiling of microbial communities and biomarker discovery in a 2026 Gut and Liver review on inflammatory bowel disease diagnostics (PMID:41220286).
- Metagenomics was highlighted as a core approach for translating gut microbiota into diagnostic readouts for inflammatory bowel disease (PMID:41220286).
- The method was used to characterize gut microbiota with sufficient resolution to support biomarker discovery rather than only taxonomic description (PMID:41220286).
- Integrated metagenomic data served as the basis for BioP-VAE, showing its utility as a derived input for downstream modeling (PMID:42026803).
Cancer and immunotherapy
- Gene-level gut microbiome signatures were used as predictive biomarkers for response to immune checkpoint inhibitors across multiple cancer types in a 2026 Gut Microbes study (PMID:42026803).
- Metagenomic data from multiple ICI-treated cohorts were integrated to build the predictive model, emphasizing cross-cohort generalizability (PMID:42026803).
- The approach linked microbiome composition to treatment response, supporting microbiome-informed precision oncology (PMID:42026803).
- The multi-cohort design suggests metagenomics can capture robust signals beyond single-study datasets (PMID:42026803).
Fermentation and multi-omics
- In a 2026 Journal of the Science of Food and Agriculture study, metagenomics was used in an integrated multi-omics analysis to elucidate microbial-metabolite interplay during mung bean sour liquid fermentation (PMID:41830297).
- The method helped explain the dynamic formation of antioxidant biomarkers during fermentation, connecting community structure to functional chemistry (PMID:41830297).
- This study illustrates metagenomics as an analytical method for linking microbial ecology with metabolite production in food systems (PMID:41830297).